TECX · ISSUER CIK 1681087
Tectonic Therapeutic, Inc.
Between Aug 1, 2026 and Oct 29, 2026, 5 Tectonic Therapeutic, Inc. insiders reported $0.00 of open-market purchases and $15K of sales on SEC Form 4.
↗5 insiders filed
Original Form 4 filings from Aug 1, 2026 to Oct 29, 2026. 3 of 3 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$15KInsider selling
−$15KNet open-market
Oct 28, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 28, 202616:30 | Oct 26, 2026 | TECX | Chief Executive Officer, Director | M · Exercise | $2.38 | +10,000 | 319,078 | +3% | $24K | ||
| Oct 2, 202617:02 | Sep 25, 2026 | TECX | Chief Financial Officer | F · TaxLate 7d | $23.67 | −520 | 58,024 | -1% | $12K | ||
| Oct 2, 202617:00 | Sep 30, 2026 | TECX | Chief Scientific Officer | S · Sell10b5-1 | $23.04 | −536 | 54,305 | -1% | −$12K | ||
| Oct 2, 202617:00 | Sep 25, 2026 | TECX | Chief Scientific Officer | F · Tax10b5-1Late 7d | $23.67 | −444 | 54,841 | -1% | $11K | ||
| Oct 2, 202616:59 | Sep 25, 2026 | TECX | Chief Medical Officer | F · TaxLate 7d | $23.67 | −525 | 67,157 | -1% | $12K | ||
| Oct 2, 202616:57 | Sep 25, 2026 | TECX | Chief Executive Officer, Director | F · TaxLate 7d | $23.67 | −1,545 | 309,078 | -0% | $37K | ||
| Oct 2, 202616:56 | Sep 25, 2026 | TECX | Chief Business Officer | F · TaxLate 7d | $23.67 | −411 | 44,903 | -1% | $10K | ||
| Aug 26, 202616:30 | Aug 25, 2026 | TECX | Chief Scientific Officer | S · Sell10b5-1 | $36.52 | −43 | 55,285 | -0% | −$2K | ||
| Aug 26, 202616:30 | Aug 25, 2026 | TECX | Chief Scientific Officer | M · Exercise10b5-1 | $14.71 | +43 | 55,328 | +0% | $632.53 | ||
| Aug 14, 202619:25 | Aug 12, 2026 | TECX | Chief Scientific Officer | S · Sell10b5-1 | $35.00 | −43 | 55,285 | -0% | −$2K | ||
| Aug 14, 202619:25 | Aug 12, 2026 | TECX | Chief Scientific Officer | M · Exercise10b5-1 | $14.71 | +43 | 55,328 | +0% | $632.53 |